Pulmonary arterial hypertension

CVRM · 1 drugs · 2 indications

Competitive Landscape (1 drugs)
DrugCompanyMechanismModalityRouteStage
WinrevairMRKActRIIA-Fc fusionFc-fusionSCAPPROVED
Indications (2)
PAH
Winrevair APPROVED
PH-LHD
Winrevair PHASE3
Upcoming Catalysts
Winrevair - PAH - Label Expansion DataCLINICAL
MRK2026
Data from Supabase · Updated 2026-03-24